Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


21 octubre 2013

Vascutek Initiates Voluntary Recall of Anaconda Bifurcate Body Stent Graft System

Endovascular Today

Vascutek Ltd. (Inchinnan, United Kingdom) announced that it issued a Field Safety Notice initiating a voluntary recall of the Anaconda bifurcate body stent graft system, which is used to treat abdominal aortic aneurysms. The company stated that an issue in the Anaconda system’s release wire in the delivery system is currently being investigated. The issue was discovered through Vascutek’s postmarket surveillance system. More than 17,000 Anaconda stent grafts have been implanted since the system was launched in 2005, noted the company.

01 noviembre 2013

Venous Patient Outcome Registry Launched by Heart and Vascular Outcomes Research Institute

Endovascular Today

The Heart and Vascular Outcomes Research Institute (HVORI, Beverly, MA) announced the launch of the Venous Patient Outcome Registry, which is designed to assess clinical outcomes for various treatments of deep and superficial venous diseases. Uchenna Onyeachom, who previously managed the American Venous Registry, serves as Director of Endovascular Research at HVORI.

15 octubre 2013

Risk for abdominal aortic aneurysms predicted by molecular imaging

Vascular News

Several newly identified markers could provide valuable insight to predict the risk of rupture of abdominal aortic aneurysms, according to new research published in the October issue of The Journal of Nuclear Medicine. Imaging with positron emission tomography/computed tomography (PET/CT) has shown that dense white blood cells in the outermost connective tissue in the vascular wall, increased C-reactive protein and a loss of smooth muscle cells in the middle layer of the vascular wall are all factors that may indicate future aneurysm rupture.

10 septiembre 2013

Sapheon completes enrolment in US pivotal study of VenaSeal

Vascular News

Sapheon announced on 9 September 2013 that it has completed enrolment in the US pivotal study of the VenaSeal Sapheon Closure System. According to the company, 242 patients have been enrolled in the study.

10 septiembre 2013

Tactile Medical launches wound care product to treat venous leg ulcers

Vascular News

Tactile Medical has launched an ambulatory device for patients with chronic wounds. The ACTitouch Adaptive Compression Therapy system combines two proven therapies—intermittent and sustained compression—in one device to heal venous leg ulcers.

24 septiembre 2013

FDA nod for Medtronic’s Complete SE vascular stent for use in lower extremities

Interventional News

On 24 September, Medtronic announced that the US Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent specifically for use in the superficial femoral artery and proximal popliteal artery. - See more at: http://www.cxvascular.com/in-latest-news/interventional-news---latest-news/fda-nod--for-medtronics-complete-se-vascular-stent-for-use-in-lower-extremities#sthash.MpRkOwEP.dpuf

19 septiembre 2013

Paclitaxel-conferring devices, whether stents or balloons, best for long-term results, meta-analysis of randomised data find

Interventional News

Konstantinos Katsanos, Interventional Radiology, Guy’s and St Thomas’ Hospitals, London, reported on data from a mixed treatment comparison network meta-analysis of randomised controlled trials comparing bare nitinol stents, covered nitinol stents, paclitaxel-eluting stents, sirolimus-eluting stents and paclitaxel-coated balloons with each other and with plain balloon angioplasty in the femoropopliteal artery.

14 septiembre 2013

New surgical table provides up to 20% reduction in C-arm radiation exposure

Interventional News

A comparative study performed to verify the new imagiQ2 low-dose table top from Stille has shown that the new device produces 20% lower radiation exposure than the previous model, imagiQ. The analysis was conducted at the Shoreline Surgical Associates Clinic, Middletown, USA, a clinic managed by vascular surgeon Joseph Coatti.

20 agosto 2013

Spectranetics launches Turbo Elite 0.035 product line extension

Vascular News

On 19 August 2013, Spectranetics announced the launch of the Turbo Elite 0.035 product line extension. The two new catheter sizes—with diameters of 2.3mm and 2.5mm—are compatible with a 0.035” guidewire, augmenting the versatility of the Turbo Elite laser to treat complex lesions including chronic total occlusions in blood vessels above and below the knee.

29 agosto 2013

Avinger receives the CE mark for Pantheris lumectomy system

Vascular News

Avinger has received CE mark approval for Pantheris—a system that combines directional atherectomy capabilities with real-time intravascular visualisation to remove plaque from blocked arteries. Pantheris is designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This new type of image-guided atherectomy is referred to as lumectomy.

25 julio 2013

DISSECT Mnemonic System Developed to Categorize Aortic Dissection

Endovascular Today

A new mnemonic-based approach to aid the categorization of aortic dissection was developed by Michael D. Dake, MD, et al of the Working Group on Aortic Diseases of the DEFINE Project. The approach, called the DISSECT classification system, was published in the European Journal of Vascular & Endovascular Surgery (2013;46:175–190).

02 octubre 2013

Additions Introduced to Biotronik’s PTA Balloon Product Line

Endovascular Today

Biotronik, Inc. (Lake Oswego, OR) announced the launch of an extension of its lower limb portfolio. The company’s Passeo-35, which is a 0.035-inch over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon, is now available in additional lengths of up to 200 mm.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.